Table 1.
Patients’ characteristics at baseline
| Patient 1 | Patient 2 | Patient 3 | Patient 4a | Patient 5 | Patient 6 | |
|---|---|---|---|---|---|---|
| Age (years) | 5.9 | 7.5 | 12.4 | 9.8 | 21.7 | 16.4 |
| Tanner stage | 1 | 2 | 2 | 1 | 5 | 5 |
| Height (Z‐score) | –2.2 | –2.0 | –3.6 | –0.1 | 0.3 | –0.7 |
| BMI (kg/m2) | 14.8 | 18.2 | 21.0 | 14.7 | 29.2 | 23.7 |
| BMI (Z‐score) | −0.5 | 1.2 | 1.0 | −1.2 | 1.7 | 0.9 |
| Diagnosis | DMD | DMD | DMD | DMD | BMD | BMD |
| Gene mutation | Dup exon 49, OOF | Del 55, OOF | Exon 32, c.4414T, p.Q1472X, OOF | Dup exon 2, OOF | Del exon 3–7, IF | Del exon 3–7, IF |
| Interventions in addition to WBLIV | DFZ, NTS, stretching | DFZ, NTS, stretching | DFZ, NTS, staluren, stretching | Pred, NTS, stretching | Stretching | Stretching |
BMD, Becker muscular dystrophy; DFZ, deflazacort; DMD, Duchenne muscular dystrophy; Del, deletion; Dup, duplication; IF, in‐frame; OOF, out‐of‐frame; WBLIV, whole‐body, low‐intensity vibration; NTS, night‐time splint; Pred, prednisone.
a
Dropped out of the study after 2 weeks due to worsening headaches.